Compare MVST & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MVST | BWAY |
|---|---|---|
| Founded | 2006 | 2003 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 245.1M | 547.7M |
| IPO Year | 2019 | 2011 |
| Metric | MVST | BWAY |
|---|---|---|
| Price | $0.66 | $12.60 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $4.50 | ★ $19.27 |
| AVG Volume (30 Days) | ★ 5.4M | 77.2K |
| Earning Date | 11-09-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 85.25 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $427,516,000.00 | N/A |
| Revenue This Year | N/A | $32.42 |
| Revenue Next Year | $29.58 | $23.40 |
| P/E Ratio | ★ N/A | $81.98 |
| Revenue Growth | ★ 12.56 | N/A |
| 52 Week Low | $0.56 | $11.77 |
| 52 Week High | $7.12 | $26.63 |
| Indicator | MVST | BWAY |
|---|---|---|
| Relative Strength Index (RSI) | 43.77 | 31.45 |
| Support Level | $0.56 | $11.90 |
| Resistance Level | $0.75 | $14.83 |
| Average True Range (ATR) | 0.04 | 0.55 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 49.27 | 0.61 |
Microvast Holdings Inc develops lithium-ion battery technologies focused on high-performance solutions for commercial and industrial electrification. The Company designs, develops, and manufactures battery components and systems for electric commercial vehicles and energy storage systems (ESS), with applications across buses, trucks, port equipment, and mining machinery. It emphasizes innovation in battery design without relying on legacy technologies and supports platforms such as the IVECO eDaily and various bus models. The Company also provides services, repairs, and warranty and extended warranty support. It operates as a single reportable segment, covering design, development, manufacturing, sales, and leasing of battery systems, and generates the majority of its revenue from Europe.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.